Literature DB >> 2580990

An immunochemical investigation of 2':3'-cyclic nucleotide 3'-phosphodiesterase (CNP) in bovine cerebrum and human oligodendroglioma.

H J Sheedlo, F Yaghmai, L Wolfe, T J Sprinkle.   

Abstract

Bovine cerebrum, including the corpus callosum, and a human oligodendroglioma were investigated by an immunohistochemical technique to determine the distribution of 2':3'-cyclic nucleotide 3'-phosphodiesterase (CNP). Also, three human oligodendrogliomas (ODG) were characterized by an immunoblot procedure to identify a protein(s) with cross-reacting determinants to CNP and assayed for CNP activity. CNP was localized to oligodendrocytes in the corpus callosum and subcortical white matter and gray matter. Also, nerve fibers appeared to be stained. Further, cells of the human oligodendroglioma were immunostained which were similar in morphology to those cells stained in the bovine cerebrum; however, fewer than 5% of the oligodendroglioma cells were immunostained. Immunoblotting revealed two separate and distinct bands for the three oligodendrogliomas, showing cross-reactivity to bovine CNP antisera at about 53,000 and 46,000 daltons. Specific CNP activity of the three human oligodendrogliomas ranged from 0.4 to 1.6 mumole of 2':3'-cAMP hydrolyzed/min/mg protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580990     DOI: 10.1002/jnr.490130309

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  2 in total

1.  Differential expression of 2':3'-cyclic nucleotide 3'-phosphodiesterase in cultured central, peripheral, and extraneural cells.

Authors:  T J Sprinkle; F A McMorris; J Yoshino; G H DeVries
Journal:  Neurochem Res       Date:  1985-07       Impact factor: 3.996

2.  Immunohistochemical characterization of oligodendrogliomas: an analysis of multiple markers.

Authors:  Y Nakagawa; E Perentes; L J Rubinstein
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.